Immune-related Encephalitis in Two Patients Treated With Immune Checkpoint Inhibitor

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Julie R. Brahmer, Christina Lacchetti, Bryan J. Schneider et al. · Journal of Clinical Oncology · 2018 · 3.7K citations · Full text

Life Sciences, Immunology, Oncology +17

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

John B.A.G. Haanen, Franck Carbonnel, Caroline Robert et al. · Annals of Oncology · 2017 · 2.4K citations · Full text

Pharmacy, Immunology, Oncology +12

Profiling Preexisting Antibodies in Patients Treated With Anti–PD-1 Therapy for Advanced Non–Small Cell Lung Cancer

Yukihiro Toi, Shunichi Sugawara, Jun Sugisaka et al. · JAMA Oncology · 2018 · 366 citations · Full text

Life Sciences, Immunology, Oncology +17

Neurological Complications Associated With Anti–Programmed Death 1 (PD-1) Antibodies

Justin Kao, Bing Liao, Svetomir N. Markovic et al. · JAMA Neurology · 2017 · 312 citations

Medicine, Neurology, Oncology +17

Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis

James Larkin, Bartosz Chmielowski, Christopher D. Lao et al. · The Oncologist · 2017 · 262 citations · Full text

Medicine, Neurology, Oncology +17